Medical Technology & Innovations, Inc Announces Success of Preliminary Trials of Female Incontinence Device.Business Editors/Health & Medical Writers RIVIERA BEACH, Fla.--(BW HealthWire)--Feb. 13, 2002 Dr. Felecia Froe spearheads the development of an innovative female incontinence device that preliminary tests show has the ability to control stress urinary incontinence stress urinary incontinence n. See stress incontinence. Medical Technology & Innovations, Inc (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB:MTIV MTIV Making the Invisible Visible (book) .ob), the company known for innovative medical devices and products, announced today that the final aspects of the urinary incontinence Urinary Incontinence Definition Urinary incontinence is unintentional loss of urine that is sufficient enough in frequency and amount to cause physical and/or emotional distress in the person experiencing it. device developed by MTIV show the device has the ability to control stress incontinence stress incontinence n. A sudden, involuntary release of urine caused by muscular strain accompanying laughing, sneezing, coughing, or exercise, seen primarily in older women with weakened pelvic musculature. . The trials are being directed by Dr. Felecia Froe, Director, UroCare for Women, LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control located in Kansas City, MO. Dr. Froe received both her undergraduate and medical degree at the University of Missouri, Kansas City. She graduated with a BA in chemistry in 1983 and graduated from medical school in 1987. She completed her six-year residency training in urology at the University of Missouri Hospital University of Missouri Hospital, or University Hospital, is one of five hospitals operated by University of Missouri Health Care in Columbia, Missouri. The hospital is part of a complex of connected hospitals and buildings including University of Missouri Children's and Clinics in 1993 and received her certification by the American Board of Urology in 1995. Dr. Froe commented "The Urinary Incontinence device developed by Medical Technology & Innovations, shows tremendous promise as a solution for women with incontinence. The trials have revealed the ability of the device to control stress urinary incontinence. The device will be a much needed solution for women everywhere who suffer from this problem". Dr Froe is the author of "Overcoming Incontinence" published in February 2000 by John Wiley, with Mary T. Dietrich, MSN (1) (MicroSoft Network) A family of Internet-based services from Microsoft, which includes a search engine, e-mail (Hotmail), instant messaging (Windows Live Messaging) and a general-purpose portal with news, information and shopping (MSN Directory). , RN, C-NP. Dr. Froe continued, "I am very happy to be working with Medical Technology & Innovations on this project. After reviewing MITV's incontinence device, I am very excited to see a new product of this magnitude. It will likely become a part of the everyday life of millions of women who suffer from stress urinary incontinence. Our mission at UroCare for Women is to provide our patients with the most up to date, technologically sound and individualized management for their Urological health, remembering and preserving at all times, the respect and confidentiality they deserve as individuals and as patients." Larry James, MTI's Senior Vice President of Research and Development said: "We have been developing this product for a number of years, and we are thrilled at these preliminary results. We plan to complete our FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. application process shortly, while moving into full scale production for world-wide distribution" Jeremy P. Feakins, Chairman and Chief Executive Officer of MTIV said: "Currently 30 million Americans are incontinent in·con·ti·nent adj. 1. Lacking normal voluntary control of excretory functions. 2. Lacking sexual restraint; unchaste. , 85% of them are women. It is estimated that 1 in 4 women ages 30-69 has experienced an episode of urinary incontinence, and 50% or more of the elderly persons living at home or in long term care facilities are incontinent. Currently 28% of women who are active in sports and 26% of women in the military suffer from stress urinary incontinence. Our new patent-pending incontinence device meets an unmet need, and promises to propel our company revenue and profits to very sizeable levels in rapid order". Note: This News Release contains certain "forward-looking statements as such term is defined in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995 and information relating to the Company are based on the beliefs of the Company's management as well as assumptions made by and information currently available to the Company's management. Such statements reflect the current risks, uncertainties and assumptions related to certain factors including, without limitations, competitive factors, general economic conditions, customer relations, relationships with vendors, the interest rate environment, governmental regulation and supervision, seasonality, distribution networks, product introductions and acceptance, technological change, changes in industry practices, and one-time events. Should any one or more of these risks or uncertainties materialize, or should any underlying assumptions prove incorrect, actual results may vary materially from those described herein. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion